The Digital Adoption and Technological Innovation in the Pharmaceutical industry--A case study of Pfizer

Authors

  • Yicheng Xiao

DOI:

https://doi.org/10.54097/7phrdd46

Keywords:

Digital Adoption, Technological Innovation, Artificial intelligence, Pharmaceutical industry, Pfizer

Abstract

With the emergence of the information age and the Covid-19 pandemic, digital transformation has become a mainstream trend among various industries. The study elaborates on the current market situation in the pharmaceutical industry and focuses on the investigation of the digital adoption and technological innovation in the pharmaceutical industry and puts forward several strategies pharmaceutical companies, Pfizer in particular, can adopt. The research adopts literature research and a case study as research methodologies. The case study carefully evaluates Pfizer, one of the leading companies in the pharmaceutical industry, and the evaluation includes Porter’s five forces, SWOT analysis, TOWS analysis, and DuPont Analysis.

Downloads

Download data is not yet available.

References

Gopal, G., Suter-Crazzolara, C., Toldo, L., & Eberhardt, W. (2018). Digital transformation in healthcare – architectures of present and future Information Technologies. Clinical Chemistry and Laboratory Medicine (CCLM), 57(3), 328–335. https://doi.org/10.1515/cclm-2018-0658 5

Biological medicine enterprise digital transformation - China academy of information and communication, the white paper. (property-and hit large reserves). http://www.caict.ac.cn/kxyj/qwfb/ztbg/202111/P020211119559015264815.pdf 10

Which industries are the most digital (and why)?. Harvard Business Review. (2020, September 14). https://hbr.org/2016/04/a-chart-that-shows-which-industries-are-the-most-digital-and-why 6

Mak, K.-K., & Pichika, M. R. (2019). Artificial Intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780. https://doi.org/10.1016/j.drudis.2018.11.014 2

Seddon, G., Lounnas, V., McGuire, R., van den Bergh, T., Bywater, R. P., Oliveira, L., & Vriend, G. (2012). Drug design for ever, from hype to hope. Journal of Computer-Aided Molecular Design, 26(1), 137–150. https://doi.org/10.1007/s10822-011-9519-9 3

Kulkov, I. (2021). The role of Artificial Intelligence in Business Transformation: A case of pharmaceutical companies. Technology in Society, 66, 101629. https://doi.org/10.1016/j.techsoc.2021.101629 1

Furtner, D., Shinde, S. P., Singh, M., Wong, C. H., & Setia, S. (2021a). Digital Transformation in medical affairs sparked by the pandemic: Insights and learnings from covid-19 ERA and beyond. Pharmaceutical Medicine, 36(1), 1–10. https://doi.org/10.1007/s40290-021-00412-w 4

Li Shizhen (2021). Pharmaceutical manufacturing technical innovation efficiency and the pharmaceutical industry growth studies (master's degree thesis, jilin university of finance and economics).https://kns.cnki.net/KCMS/detail/detail.aspx?dbname=CMFD202201&filename=1021720583.nh 7

Yang Songling, Wang Zhihua, Liu Tingli & Niu Dengyun.(2019). The impact of firm innovation input on industry growth: The moderating effect of industry R&D environment and firm market power. Science and Technology Progress and Countermeasures (02),59-68. 8

Liu, F., Yang, Z. & Yang, X. (2016). Management Review (02),61-73. doi:10.14120/j.cnki.cn11-5057/f.2016.02.006. 9

Mikulic, M. (n.d.-b). Topic: Pfizer. Statista. https://www.statista.com/topics/1394/pfizer/

Sun, D., Gao, W., Hu, H., & Zhou, S. (2022). Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B, 12(7), 3049–3062. https://doi.org/10.1016/j.apsb.2022.02.002

Pharmaceuticals in the environment. Pfizer. (n.d.). https://www.pfizer.com/about/responsibility/environmental-sustainability/pharmaceuticals-in-the-environment

Environmental sustainability. Pfizer. (n.d.-a). https://www.pfizer.com/about/responsibility/environmental-sustainability

Under stable earnings Numbers, Pfizer malaise actually. (property-and hit large reserves). https://baijiahao.baidu.com/s?id=1724877976629486325& wfr=spider& for=pc

Information Center. How can pharmaceutical companies reduce the cost of new drug development? _, new drug research and development costs - pharmaceutical network. (property-and hit large reserves). https://www.zyzhan.com/news/detail/73535.html

Pfizer’s financial performance in 2022. Pfizer’s financial performance in 2022 | Pfizer 2022 Annual Report.(n.d.-a).https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/performance/

Downloads

Published

29-12-2023

How to Cite

Xiao, Y. (2023). The Digital Adoption and Technological Innovation in the Pharmaceutical industry--A case study of Pfizer. Highlights in Business, Economics and Management, 23, 45-51. https://doi.org/10.54097/7phrdd46